Search results
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Zacks via Yahoo Finance· 6 hours agoAnd, most ETFs are very transparent products that disclose their holdings on a daily basis. For XBI,...
Gateway - Quartz
Quartz· 7 days agoThe US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The move marks a major investment in the country even as relations ...
The FDA awarded a record number of review designations to mRNA vaccines in 2023
Pharmaceutical Technology via Yahoo Finance· 1 day agoFollowing FDA approval in August 2021, Pfizer’s Comirnaty became the first mRNA vaccine to enter the...
‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu...
Fortune via Yahoo Finance· 23 hours agoMeanwhile, the government is in conversations with Pfizer and Moderna, but anything that gets...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 6 days agoRasmussen Reports used to be a fairly creditable and credible political polling organization, good...
Lab-as-a-service for biotech startups opens in Basel, Switzerland
TNW· 2 hours agoIt is notoriously difficult for startups in life sciences and biotechnology to get investments for...
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Zacks· 12 hours agoLaunched on 01/31/2006, the SPDR S&P Biotech ETF (XBI Quick QuoteXBI - Free Report) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market ...
There may be an increase in COVID cases this summer. Experts say this is why many shouldn't be...
ABC News· 6 days agoAs the United States heads into the summer season, early indicators show the country is likely to...
Army linked soldier's heart condition to COVID vaccine, former CBS News journalist reports
WCHS-TV· 1 day agoThe U.S. Army and National Guard acknowledged a soldier’s “debilitating heart condition” is...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days agoSince then, the stock has pulled back. The vaccine is based on protein technology, differentiating...
